Monday, April 28, 2025

Latest

Tag: Compass Pathways

Compass Pathways President Steps Down To An Advisory Role

Compass Pathways (Nasdaq: CMPS) announced this morning major changes to its executive team. One of its co-founders, President and Chief Business Officer Lars Wilde is stepping down to take a senior advisory role.

“We have built an amazing company at COMPASS and I am grateful to everyone who continues to support us,” Wilde said in a statement. “This is a natural time for me to transition to an advisory role and I am proud to be able to continue working with COMPASS.”

The move is effective as of January 1, 2022.

Wilde is said to have been integral to the company’s strategic and operational efforts, “including fundraising, business development, and the development of its Discovery Center.”

The firm also announced Matthew Owens as its General Counsel and Chief Legal Officer starting February 1, 2022, while Mike Falvey was announced as the incoming CFO earlier this month.

Compass Pathways last traded at US$23.73 on the Nasdaq.


Information for this briefing was found via Edgar and Compass Pathways. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Compass Pathways Granted Its Tenth Overall Patent Related To Psilocybin

November 23, 2021, 07:55:20 AM

Compass: Canaccord Reiterates $80 Price Target After Study Data

November 22, 2021, 02:44:00 PM

Compass Pathways Sees “Reduction In Depressive Symptom” In Phase IIb Psilocybin Clinical Trial

November 9, 2021, 12:33:00 PM

Compass Pathways To Start Phase II Trial For Psilocybin PTSD Therapy

November 3, 2021, 09:52:00 AM

Compass Pathways Closes Enrollment For Phase IIb Psilocybin Clinical Trial

June 28, 2021, 07:37:00 AM

Psychedelics: The Eight Capital Primer

June 14, 2021, 03:38:00 PM

David Nutt: Amanita Muscaria Due For More Research – The Daily Dive

March 10, 2021, 01:30:00 PM

Compass Pathways Leader Of Investment Climate For Psychedelic Plays – The Daily Dive feat Jeff Stevens

December 30, 2020, 01:30:00 PM

Psychedelics & The Need For Digital Therapeutic Solutions In Treating Mental Health

November 1, 2020, 09:00:00 AM

Andrew Left’s Citron Research Places $100 Price Target On Compass Pathways

October 5, 2020, 07:01:00 PM

Compass Pathways, Psilocybin Research Firm, Files For Nasdaq IPO

August 29, 2020, 11:43:00 AM
Video Articles

Bell Q3 Earnings: Massive Impairments. Guidance Cuts. A Mess.

Alamos Gold Q3: Record Revenue & Production Amid Rising Costs

The Junior Mining Market Is Back

Recommended

Germany Looks To Modernize Military Recruitment But Stops Short of Conscription

First Majestic Silver Posts Topline Revenue Of $146.1 Million In Q3 2024